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Purpose. A line of transgenic mice containing the simian virus (SV) 40 T-antigen (T-ag) gene 
driven by the beta-luteinizing hormone (BLH) promoter developed bilateral retinoblastoma 
and primitive neuroectodermal tumors (PNET) of the midbrain. Midbrain tumors arose 
from the subependymal layer of the cerebral aqueduct. Bilateral ocular and brain tumors 
("trilateral") were found in three other SV40 T-ag transgenic murine lines containing differ-
ent promoters (murine interphotoreceptor retinoid-binding protein (IRBP), human IRBP, 
and alpha A-crystallin). To gain insight into the regulatory mechanisms involved in central 
nervous system tumorigenesis, the authors examined brain tumors from four lines of SV40 
T-ag mice with different promoters. 
Methods. Formalin-fixed brain tumors were examined from four lines of transgenic mice 
containing different promoters linked to the protein coding region of the enhancerless SV40 
T-ag oncogene. Transgenes contained the following promoters: BLH, mouse l.8-kb IRBP, 
human 1.3-kb IRBP, and alpha A-crystallin. 
Resultf. Mice with a 1.8-kb IRBP promoter develop retinal photoreceptor and pineal tumors. 
Intracranial tumors arising from the subependymal layer of the third ventricle also were 
observed. Mice with a 1.3-kb IRBP promoter exhibit bilateral retinal PNET and PNET originat-
ing from the subependymal layer of the third ventricle. Mice with the alpha A-crystallin 
promoter exhibit bilateral lens tumors and PNET of the midbrain. 
Conclusions. Ocular tumors in these mice may be ascribed to the promoter-driven, tissue-
specific expression of SV40 T-ag. The common finding of PNET arising from the subependy-
mal layer of the diencephalon is unlikely to be promoter related. These findings indicate that 
a regulatory region specific to the subependymal layer of the cerebral aqueduct and third 
ventricle resides in the structural region of the SV40 T-ag gene. Invest Ophthalmol Vis Sci. 
1996;37:392-396. 
In humans, the rare associatIon of retinoblastoma 
with a similar primary intracranial midline neoplasm 
is known as "trilateral retinoblastoma.,,1-4 We have 
described the murine counterpart of trilateral retino-
blastoma occurring in transgenic mice containing the 
beta luteinizing hormone promoter (BLH) gene fused 
to the simian virus 40 (SV40) large T antigen (T-ag) 
oncogene.5 ,6 These mice exhibited retinal-specific ex-
pression of SV40 T-ag, resulting from regulatory ef-
fects exerted by the transgene integration site, and 
they represent the first heritable model of retinoblas-
toma.7 Although ocular tumors are observed in 100% 
of transgene-bearing mice, central nervous neoplasms 
occur at a lower rate (27%). Transgenic brain tumors 
are primitive neuroectodermal tumors (PNET) of the 
midbrain and arise from the subependymal cells of 
the cerebral aqueduct.6 
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Human intracranial trilateral retinoblastoma oc-
curs in the region of the pineal or as a suprasellar or 
parasellar neoplasm.3.4 The absence of primary pineal 
involvement in the BLH transgenic mouse model indi-
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cates that murine midbrain PNET represents a model 
for the suprasellar or parasellar form of human trilat-
eral retinoblastoma.6 
The development of central nervous system tu-
mors in transgenic mice expressing T-ag is not unique 
to the BLH mouse model of retinoblastoma. Other 
lines of T-ag transgenic mice develop choroid plexus 
papillomas at 3 to 5 months of age.8,9 The SV40 en-
hancer (72-bp repeat region) seems to direct expres-
sion ofSV40 T-ag to the choroid plexus in the majority 
of transgenic mice. Choroid plexus tumors selectively 
express SV40 T-ag, a requirement for tumorigenesis 
in these animals. Transgenic mice with the JC virus T-
ag under the control of the SV40 enhancer also de-
velop choroid plexus tumors, providing direct evi-
dence that SV40 viral regulatory regions playa critical 
role in determining the tissue specificity of viral onco-
gene expression. 10 
Substitution of tissue-specific promoter-en-
hancer elements for the SV40 enhancer redirects ex-
pression of T-ag to specific cell types and greatly re-
duces the incidence of choroid plexus tumors. For 
example, fusion of enhancerless SV40 T-ag genes 
(BglI site to the Bam HI site of SV40 early region) to 
regulatory regions of elastase, II insulin,12 and atrial 
natriuretic factor l3 result in transgenic mice with pan-
creatic acinar cell, pancreatic islet cell, and heart cell 
tumors, respectively. 
Fusion of enhancerless SV40 T-ag to regulatory 
regions of various ocular-specific genes has resulted 
in the ocular-specific expression of SV40 T-ag with 
resultant ocular neoplasia. Transgenic mice carrying 
the murine alpha A-crystallin promoter fused to the 
enhancerless SV40 T-ag oncogene develop lens tu-
mors.14 Expression of SV40 T-ag under the control of 
a 1.3-kb human interphotoreceptor retinoid-binding 
protein (IRBP) causes bilateral retinal primitive neu-
roectodermal tumors. 15 In addition, a 1.8-kb murine 
IRBP promoter linked to the SV40 T-ag oncogeny pro-
duce transgenic mice with similar photoreceptor cell 
tumors. 16 
Interestingly, trilateral brain tumors also are seen 
in 100% of mice with the 1.3- and 1.8-kb IRBP promot-
ers. 15,16 The precise origin of brain tumors was not 
established clearly in the 1.3-kb IRBP model. In the 
1.8-kb IRBP promoter model, brain tumors were dem-
onstrated to be pineal in origin. This finding is not 
unexpected because IRBP is expressed normally 
within the pineal gland. However, we have since iden-
tified a second primary intracranial tumor in the 1.8-
kb IRBP model. In addition, mice with the alpha crys-
tallin promoter were found to develop midline central 
nervous system tumors. 
What is directing SV40 T-ag to the brain of these 
animals? Are these central nervous system tumors simi-
lar? We addressed these questions by examining brain 
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tumors from transgenic mice carrying the alpha-crys-
tallin, 1.3-, and 1.8-kb IRBP promoters fused to an 
enhancerless SV40 T-ag gene and compared them to 
the primitive neuroectodermal tumors found in mice 
with trilateral retinoblastoma. 
MATERIALS AND METHODS 
Four formalin-fixed, paraffin-embedded brain tumors 
occurring in 3-week-old trangenic mice carrying the 
1.8-kb mouse IRBP promoter linked to the SV40 T-
ag oncogene were examined. 16 The 1.8-kb IRBP T-
ag transgene has been described 16 and contains the 
promoter region of the mouse IRBP gene (-1783 to 
+ 101) linked to an enhancerless-promoterless SV40 
T-ag early region encoding large and small T-anti-
gens. 16 
We examined formalin-fixed brain tumors from 
mice encoding the 1.3-kb promoter of the human 
IRBP gene fused to the 5' end of the enhancerless-
promoterless SV40 T-ag gene. 15 These mice have been 
described. 15 
We examined four formalin-fixed, paraffin-em-
bedded brain tumors occurring in transgenic mice (3 
to 5 months of age) carrying the murine alpha A-
crystallin promoter fused to an enhancerless SV40 T-
ag. 14 The alpha A-crystallin-SV40 T-ag construct has 
been described. 14 · The 412-bp alpha crystallin se-
quence (-366 to +46) contains the promoter and 
cap site. The promoter was fused to an enhancerless-
promoterless SV40 early region containing coding se-
quences for both large and small T-antigens and poly-
adenylation signals. 14 All animals were killed hu-
manely in accordance with the ARVO Statement for 
the Use of Animals in Ophthalmic and Vision Re-
search. 
RESULTS 
The 1.8-kb (murine IRBP promoter) IRBP T-ag mice 
demonstrated the development of retinal photorecep-
tor cell and pineal tumors by 2 weeks of age. 16 Pre-
viously described pineal tumors display Homer Wright 
rosettes.16 Pineal tumors fill the transverse fissure of 
the cerebrum, spread through the pia mater, and by 
5 weeks invade the outer molecular layer of the collicu-
Ius posterior and below the cerebral hemispheres. 16 
A second primary midline intracranial tumor can 
be identified at 3 weeks in the ventral portion of the 
third ventricle, at the level of the infundibulum hypo-
thalami. This tumor is composed of lightly hyperchro-
matic monomorphous cells with scanty cytoplasm and 
round nuclei with sparse chromatin. Numerous mito-
ses are present, but there is no evidence of rosette 
formation or differentiation. Serial sections of four 
mouse brains demonstrate that the tumor originates 
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from the subependymal laycr of the floor of the third 
ventricle (Fig. 1). These cel ls encircle the base of the 
insertion of the pituitary sralk and spread anteriorly. 
SeriaJ sections indicate no evidence of intracranial ex-
tension from ocular tumors. 
All transgenic mice with the l.3-kb human lRBP 
promoter exhibited retinal and brain tumors. As pre-
viously described, 15 sections of brain tumors revealed 
poorly d ifferentiated neoplasms with histologic fea-
tures (ound in primitive neuroectodermal tumors of 
infancy. Homer Wright rosettes were evident in some 
of the brain tumors examin ed. 
Tri lateral brain tumors appeared in early postna-
flGURE J. Simian \irus 40 Tantigen mouse with II l.&.kb 
murine interphotoreceptor retinoid-binding protein pro-
moter de~'e lops retinal photoreceptor and pineal tumors. A 
5e<:ond primary midline intracranial tumor is evident at 3 
weeks of age. (A) Transverse lind (8 ) sagittal sections dem-
onst.-"tc that this tumor (Tl is located in the vemnll pOrlion 
of the third ventricle (3V), at the level ofllle infundihululll 
hypothabl.mi (hematoxylin and eosin x80, x200). (C) Ar-
rowhead corresponds to arrolV noted in B, demonstrating 
that this tUlllor (T) is composed of lightly hyperchromatic, 
monomorphous cells with scanty cytoplasm and round nu-
clei with sparse chromatiu. No rosette fonnation is seen. 
Serial sections demonstrate the rumor originating from the 
subependymal layer of the floor of the third ventricle (hema-
toxylin and eosin, X400). [p "" e pendYlllal epithelium of 
third ventricle; A "" a rcuate hypothalamic nucleus: P Pit 
= posterior lobe of pituitary: I Pit :::: inte.mediate lobe of 
pituitary; A Pit = anterior lobe of pituitary; IRe = infundibu-
lar recess of third vcnDicle; B = basisphenoid bone; M Re 
= mamillary recess of third ventricle; PitS = pi tuitary stalk . 
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tal stages. Brain tumors involved mostly lhe dienceph-
alon, adjacent to the floor of the third ventricle, and 
surrounded the habenula nuclei without involving the 
choroid plexus.'~ These tumors also seem to originate 
from the subependymal cells (Fig. 2). With extension, 
tumors involved the midbrain, cerebr.:tl aqueduct, and 
fourth ventricles. 
Although lens-specific transgene expres."ion re-
sulted in ocular lens tumors' ~ in the crystallin pro-
moter model, brain tumors developed at a lower rate. 
Microscopic examination of four brain tumors from 
mice of the crystallin promotor model revealed that 
three of these neoplasms were histologically and ana-
tomically similar [0 those fou nd in BLH-promoter 
transgenic mice ,vith retinoblasloma.G These midbrain 
neoplasms were located within the subependymal 
layer of lhc cerebral aqueduct and floor of tlle third 
venu-icle (Fig. 3). These tumors also demonstrated 
cytologic features iden tical to those ofl.r.msgenic mice 
with retinoblastoma,6 These features consisted of the 
following: giant cells, anisonucleosis, euchromatin, 
hyperchromatism, indistinct cytoplasm, foci of miner-
alization, and a high mitotic index, The fourth mouse 
did not demonstrate a midbrain malignancy but har-
bored a choroid plexus carcinoma of the fourth ventri-
cle, typical of that described in previous SV40 T-ag 
transgenic mice.II.~ 
DISCUSSION 
Introduction of the SV40 T-ag oncogene into tlle 
germline of tr.tnsgcnic ~"ice allows for the expression 
ofT-ag in various tissues, often resulting in neoplasia. 
The site of T-ag expression may be determined by 
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FIGUK£ 'to Tran!;verse section of simian virus 40 T-antigcn 
mouse with a 1.3-kb human intcrphol.Oreceptor retinoid-
binding protein promoter demonstrating brain tulilor (T) 
arising from the subepend}'lllal floor of the third ventricle. 
D~pla~ tic liuhependymal cells (arrowheads) are noted wifh in 
the Ct.!rcbr.d aqueduct (hematoxylin and eosin, X 100). Ep 
= ependym<ll epithelium of ccrc;bnll aqueduct; T - tumor. 
the con trol of its natural viral en hancer (72-bp repeat 
region), by a tissue-specific promoter element as part 
of a fu~ion construct, b)' regulatory regions adj acent 
to or at a distance from the site of transgene in tegra-
tion, o r by seq uences residing in the SV40 T-ag gene. 
T he occurrence of similar central nervous system 
malignancies in four lines of transgen ic mice con-
tain ing different promoters fused to en hancerless-
promoterless SV40 T-ag genes suggesLS !.he pf:esence 
of some common specificity fo r exprt!ssion ofT-ag ill 
the subependymal layer o f the third. ve ntricular floor 
and cerebral aqueduct in these mice. If the promoters 
or tran~genc insertion sites o f these mice contained 
similar regulatory sequences, a common pattern of 
ocular tumorigenesis (and correspondingT-ag expres-
sion) would be expected. This does not occur; lens 
tumo rs, photoreceptor cell tumors, and retinoblas-
toma arising from the inner nuclear layer are specific 
to each line of mice. It is. lherelore. unlikely that a 
common regulatory mechanism exists within the BU-I 
promoter, a lpha-crystallin promoter, h uman and 
mouse IRBP promoters, or an unidentified retinal en-
hancer region. 
The obvious link between these transgen ic mouse 
constructs appears to be the SV40 T-ag gene ilself. 
O ur findings suggest that a regulatory regio n specific 
to the subependymal la}'er of the cerebral aqueduct 
and noor of !.he third ventricle resides in the structural 
region of the SV40 T-ag gene. 
In further support of this hypothesis, transgenic 
mice containing a mouse opsin promoter fused to 
SV40 T-ag demonstrate photoreceptor degeneration 
secondary to T-ag retinal expression. In terestingly, 
these mice also developed a PN£T of the midbrclin 
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dose to, or under, the ependymal cells lining the 
fourth venlricle .17 The origin of these central ne\Vous 
system tumOI1i is under investigation . In additjon, 
transgenic mice with a construct containing the hu-
man beta-actin promoter regulating human papillo ma 
virus (HPV) 16 £6 and £7 oncogenes demonstrate 
sim ilar neuroepithelial tUmors associated with the ep-
endyma of the third and fou rth ventricles. T hus, it 
seems that a regulatory region specific to this area 
of the central nervous syste m also may reside in the 
structural region of the HPV £6 and £7 oncogenes. III 
Ou r h}'pothesis is supported by the proposal of 
Messing et all!' that SV40 T-ag sequences may playa 
role in lhe tissue-specific expression ofT·ag to choroid 
plexus, thymus, and kidney. Although the 72-bp en-
hancer appears to be importan l in the development 
of choroid plexus papillomas and in nonmalignant 
lesions of the kidney and thymus,~ thymic and choroid 
picxus lesions have occurred in mice lacking the SV40 
enhancer.9.w The existence of regu latory elements 
, , 
A B 
FlGURE:S. (A) Transverse section of a si mian vims 40 T-anti-
gel! mouse \"ith an alpha A<ryslallin promoter demonstra-
ting a br.~in tulllor arising (rom the floor or fhe thi rd ventri-
de (hemaLOxylin and eosin, Xl OO). (8 ) Low- and (C) high-
power views from a transverse section of an early br~in tumor 
from simian virus 40 T-antigen mouse with an alpha A-crys-
taUin Pl'Omoter identifying rumor arising rrom the subepe h-
dYInal layer (arrmllhearLl) of the lloor of the third venl.ricle · 
(hematoxylin <lnd eosin, X40, X400). 3V = th ird ventricle; 
C = cerebral aqueduct; Ep = ependymal epithelium ofthird 
ventricle; T = tumor. 
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within the SV40 T-ag gene is supported further by our 
finding of a choroid plexus tumor in the alpha A-
crystallin mouse. 
If the development of this malignancy is deter-
mined by SV40 T-ag sequences, why has this tumor 
not been previously identified? There are reasons for 
the lack of reports of midbrain tumorigenesis in other 
SV40 constructs. With tissue-specific promoters, em-
phasis is placed on the predicted site of tumor forma-
tion, and examination of the central nervous system 
often is omitted. In addition, many lines of transgenic 
mice with malignancies of vital organs (i.e., heart, kid-
ney) die before the expected onset of midbrain PNET. 
The observation of midbrain PNET in the current 
study is the result of systematic examination of the 
pineal gland and suprasellar and parasellar regions of 
many mice, in search of the murine trilateral tumors. 
Because these tumors are not grossly apparent, this 
region must be examined microscopically to identify 
them. We suspect that PNET of the midbrain and 
third ventricle is relatively common in transgenic mice 
with enhancerless SV40 constructs fused to various 
tissue-specific promoters. Identification and isolation 
of the exact regulatory region within the SV40 gene 
specific for subependymal cells may prove valuable. 
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